Metal nanoparticles for cancer therapy: Precision targeting of DNA damage

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Cancer is a complex disease driven by genomic instability.
• Current DNA damage-based therapies (radiotherapy, chemotherapy) have limitations in efficacy and safety.
• Metal nanoparticles offer potential solutions to overcome these therapeutic constraints.

Purpose of the Study:

• To review the design principles and optimization strategies of metal nanoparticles for cancer therapy.
• To highlight how metal nanoparticles can address limitations in DNA damage-based cancer treatments.
• To explore the role of physicochemical properties in metal nanoparticle-based therapeutic platforms.

Main Methods:

• Review of existing literature on metal nanoparticles in cancer therapy.
• Analysis of strategies for targeted drug delivery, DNA repair inhibition, and cell death induction.
• Exploration of physicochemical factors influencing nanoparticle performance.

Main Results:

• Metal nanoparticles can be customized for targeted drug delivery and personalized treatment.
• Strategies include inhibiting DNA repair, inducing cell death, and modulating immune responses.
• Physicochemical properties like size, stimuli-responsiveness, and surface modification are crucial.

Conclusions:

• Metal nanoparticles represent a promising platform for advancing DNA damage-based cancer therapy.
• Further research into challenges and future directions is needed for novel treatment paradigms.
• Optimized metal nanoparticles can improve the efficacy and safety of cancer treatments.